Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2025 08:59 ET | Source: Research and Markets

Congenital Hyperinsulinism Market Research Report 2025-2035: Gene and Targeted Therapies Accelerate as New Insights Into ABCC8 and KCNJ11 Mutations Transform Treatment Landscape

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Congenital Hyperinsulinism Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report...
November 17, 2025 08:00 ET | Source: SNS Insider pvt ltd

Protein Therapeutics Market Set to Hit USD 645.61 Billion by 2032 as Biologics, Precision Medicine, and Advanced Biotechnology Accelerate Global Adoption – SNS Insider

Austin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Protein Therapeutics Market Size & Trends: According to SNS Insider, The Protein Therapeutics Market size was valued at USD 375.32 billion in 2024 and...
November 14, 2025 06:30 ET | Source: Embecta Corp.

embecta Announces Major New Commitment to Direct Relief on World Diabetes Day

embecta and Direct Relief announce a significant expansion of their partnership to increase access to diabetes care for communities worldwide
November 11, 2025 10:02 ET | Source: Research and Markets

Diabetic Ketoacidosis Treatment Market Research Report 2025 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2020-2030F

Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Diabetic Ketoacidosis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
November 11, 2025 09:48 ET | Source: Research and Markets

Insulin Storage Devices Market Trends, Opportunities, and Forecast, 2020-2024 & 2025-2030 - Rising Adoption of CGM Systems, Insulin Pumps, and AI-enabled Smart Storage Solutions Driving Demand

Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Insulin Storage Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
November 06, 2025 10:38 ET | Source: Research and Markets

Rapid Acting Insulin Market Analysis, Trends and Competitive Landscape 2025-2033 - Advancements in Insulin Delivery Tech Propel Market Growth

Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Rapid Acting Insulin Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's...
November 03, 2025 06:08 ET | Source: Research and Markets

The Insulin Pen Market in Japan, 2025-2033 - Rising Demand for Easy-to-Use Insulin Pens Amid Japan's Aging Population Drive Revenues to a Projected $515 Million by 2033

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Japan Insulin Pen Market Growth Outlook 2025-2033" has been added to ResearchAndMarkets.com's offering.The Japan Insulin Pen Market is forecasted to...
October 21, 2025 09:30 ET | Source: Research and Markets

United States Rapid Acting Insulin Research Report 2025: A $3.4 Billion Market by 2033 Featuring Adocia, Biocon, Eli Lilly, Gan & Lee, Geropharm, MannKind, Merck, Novo Nordisk, Sanofi, Wockhardt

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "United States Rapid Acting Insulin Market Report by Product, Indication, Distribution Channel, States and Company Analysis, 2025-2033" report has been...
October 16, 2025 06:20 ET | Source: Research and Markets

U.S. Semaglutide Market Trends and Investment Strategies 2025-2033: Retail Pharmacies Play Key Role in Distribution Amid Growing Demand

Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "United States Semaglutide Market Report by Product, Application, Distribution Channel, States and Company Analysis, 2025-2033" has been added to ...
September 25, 2025 02:30 ET | Source: Arecor Therapeutics PLC

Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292

Arecor Therapeutics announces Co-development Agreement for AT278 with Sequel Med Tech and Sale of Royalty and Technology Access Fees for up to $11m